 Antibodies virus followed patients posttransfusion hepatitis attempt incidence clinical course type viral hepatitis patients posttransfusion hepatitis antibodies virus anti-HCV sera cardiovascular surgery patients hepatitis blood transfusions anti-HCV seroconversion follow-up period mean interval blood transfusion onset active anti-HCV seroconversion months first elevation serum alanine aminotransferase levels weeks correlation fluctuations serum alanine aminotransferase levels anti-HCV titers patients type posttransfusion hepatitis year abnormal serum alanine aminotransferase levels results HCV major agent posttransfusion hepatitis Taiwan important role chronic hepatitis transfused patients